Beta Bionics (BBNX) Institutional Ownership $16.40 -0.39 (-2.32%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Beta Bionics (NASDAQ:BBNX)Number ofInstitutional Buyers(last 12 months)29TotalInstitutional Inflows(last 12 months)$203.68MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$122.68K Get BBNX Insider Trade Alerts Want to know when executives and insiders are buying or selling Beta Bionics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BBNX Institutional Buying and Selling by Quarter Beta Bionics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/1/2025Jennison Associates LLC59,185$862K0.0%-12.5%0.137% 7/29/2025 Values First Advisors Inc.42,563$620K0.3%+13.2%0.098% 7/25/2025 CWM LLC4,011$58K0.0%N/A0.009% 7/15/2025 Palumbo Wealth Management LLC29,579$431K0.1%N/A0.068% 6/27/2025Goldman Sachs Group Inc.58,422$715K0.0%N/A0.135% 5/29/2025Rhumbline Advisers12,880$158K0.0%N/A0.030% 5/28/2025Strs Ohio2,400$29K0.0%N/A0.006% 5/16/2025Woodline Partners LP125,000$1.53M0.0%N/A0.288% 5/16/2025Goldman Sachs Group Inc.58,422$715K0.0%N/A0.135% 5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,772$95K0.0%N/A0.018% Get the Latest News and Ratings for BBNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beta Bionics and its competitors with MarketBeat's FREE daily newsletter. 5/16/2025Eventide Asset Management LLC4,928,019$60.31M1.2%N/A11.366% 5/16/2025Alyeska Investment Group L.P.75,000$918K0.0%N/A0.173% 5/15/2025RA Capital Management L.P.500,000$6.12M0.1%N/A1.153% 5/15/2025Braidwell LP140,000$1.71M0.1%N/A0.323% 5/15/2025Ghisallo Capital Management LLC50,000$612K0.1%N/A0.115% 5/15/2025Driehaus Capital Management LLC882,277$10.80M0.1%N/A2.035% 5/15/2025Omega Fund Management LLC1,988,287$24.34M14.4%N/A4.586% 5/14/2025Corebridge Financial Inc.6,485$79K0.0%N/A0.015% 5/14/2025MetLife Investment Management LLC8,370$102K0.0%N/A0.019% 5/14/2025Walleye Capital LLC148,105$1.81M0.0%N/A0.342% 5/14/2025Sands Capital Ventures LLC3,103,782$37.99M9.3%N/A7.159% 5/14/2025Wellington Management Group LLP3,901,599$47.35M0.0%N/A8.999% 5/13/2025Lord Abbett & CO. LLC228,160$2.79M0.0%N/A0.526% 5/12/2025Nuveen LLC17,044$209K0.0%N/A0.039% 5/12/2025Invesco Ltd.16,464$202K0.0%N/A0.038% 5/9/2025Deutsche Bank AG12,079$148K0.0%N/A0.028% 5/9/2025Charles Schwab Investment Management Inc.101,614$1.24M0.0%N/A0.234% 5/7/2025 TD Asset Management Inc39,876$488K0.0%N/A0.092% 5/5/2025Jennison Associates LLC67,611$828K0.0%N/A0.156% 4/30/2025 Values First Advisors Inc.37,585$457K0.3%N/A0.087% 4/29/2025Bank of New York Mellon Corp25,793$316K0.0%N/A0.060% 4/22/2025 Evanson Asset Management LLC38,772$475K0.0%N/A0.089% 4/8/2025Rhumbline Advisers12,880$158K0.0%N/A0.030% (Data available from 1/1/2016 forward) BBNX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BBNX shares? During the previous two years, 29 institutional investors and hedge funds held shares of Beta Bionics. The most heavily invested institutionals were Eventide Asset Management LLC ($60.31M), Wellington Management Group LLP ($47.35M), Sands Capital Ventures LLC ($37.99M), Omega Fund Management LLC ($24.34M), Driehaus Capital Management LLC ($10.80M), RA Capital Management L.P. ($6.12M), and Lord Abbett & CO. LLC ($2.79M).Learn more on Beta Bionics' institutional investors. Which institutional investors have been buying Beta Bionics' stock? Of the 29 institutional investors that purchased Beta Bionics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($4.93M), Wellington Management Group LLP ($3.90M), Sands Capital Ventures LLC ($3.10M), Omega Fund Management LLC ($1.99M), Driehaus Capital Management LLC ($882.28K), RA Capital Management L.P. ($500K), and Lord Abbett & CO. LLC ($228.16K). How much institutional buying is happening at Beta Bionics? Institutional investors have bought a total of 16,633,266 shares in the last 24 months. This purchase volume represents approximately $203.68M in transactions. Which of Beta Bionics' major shareholders have been selling company stock? The following institutional investors have sold Beta Bionics stock in the last 24 months: Jennison Associates LLC ($8.43K). How much institutional selling is happening at Beta Bionics? Institutional investors have sold a total of 8,426 shares in the last 24 months. This volume of shares sold represents approximately $122.68K in transactions. Related Companies Warby Parker Institutional Ownership LivaNova Institutional Ownership National Vision Institutional Ownership LeMaitre Vascular Institutional Ownership NovoCure Institutional Ownership Enovis Institutional Ownership CONMED Institutional Ownership Liquidia Technologies Institutional Ownership Cadre Institutional Ownership Artivion Institutional Ownership This page (NASDAQ:BBNX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beta Bionics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beta Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBNX Stock Alerts